Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats

Detalhes bibliográficos
Autor(a) principal: Macedo, Anderson G. [UNESP]
Data de Publicação: 2023
Outros Autores: Miotto, Danyelle S. [UNESP], Tardelli, Lidieli P. [UNESP], Santos, Carlos F., Amaral, Sandra L. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3389/fphys.2023.1147525
http://hdl.handle.net/11449/249101
Resumo: Angiogenesis is an important exercise-induced response to improve blood flow and decrease vascular resistance in spontaneously hypertensive rats (SHR), but some antihypertensive drugs attenuate this effect. This study compared the effects of captopril and perindopril on exercise-induced cardiac and skeletal muscle angiogenesis. Forty-eight Wistar rats and 48 SHR underwent 60 days of aerobic training or were kept sedentary. During the last 45 days, rats were treated with captopril, perindopril or water (Control). Blood pressure (BP) measurements were taken and histological samples from the tibialis anterior (TA) and left ventricle (LV) muscles were analyzed for capillary density (CD) and vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2) and endothelial nitric oxide synthase (eNOS) protein level. Exercise increased vessel density in Wistar rats due to higher VEGFR-2 (+17%) and eNOS (+31%) protein level. Captopril and perindopril attenuated exercise-induced angiogenesis in Wistar rats, but the attenuation was small in the perindopril group, and this response was mediated by higher eNOS levels in the Per group compared to the Cap group. Exercise increased myocardial CD in Wistar rats in all groups and treatment did not attenuate it. Both exercise and pharmacological treatment reduced BP of SHR similarly. Rarefaction was found in TA of SHR compared to Wistar, due to lower levels of VEGF (−26%) and eNOS (−27%) and treatment did not avoid this response. Exercise prevented these reductions in control SHR. While rats treated with perindopril showed angiogenesis in the TA muscle after training, those rats treated with captopril showed attenuated angiogenesis (−18%). This response was also mediated by lower eNOS levels in Cap group compared with Per and control group. Myocardial CD was reduced in all sedentary hypertensive compared with Wistar and training restored the number of vessels compared with sedentary SHR. In conclusion, taken into account only the aspect of vessel growth, since both pharmacological treatments reduced BP in SHR, the result of the present study suggests that perindopril could be a drug of choice over captopril for hypertensive practitioners of aerobic physical exercises, especially considering that it does not attenuate angiogenesis induced by aerobic physical training in skeletal and cardiac muscles.
id UNSP_281ec4574787697019053836a9f2f3b4
oai_identifier_str oai:repositorio.unesp.br:11449/249101
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive ratsACE inhibitorsaerobic trainingeNOStibialis anteriorVEGFvessel growthAngiogenesis is an important exercise-induced response to improve blood flow and decrease vascular resistance in spontaneously hypertensive rats (SHR), but some antihypertensive drugs attenuate this effect. This study compared the effects of captopril and perindopril on exercise-induced cardiac and skeletal muscle angiogenesis. Forty-eight Wistar rats and 48 SHR underwent 60 days of aerobic training or were kept sedentary. During the last 45 days, rats were treated with captopril, perindopril or water (Control). Blood pressure (BP) measurements were taken and histological samples from the tibialis anterior (TA) and left ventricle (LV) muscles were analyzed for capillary density (CD) and vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2) and endothelial nitric oxide synthase (eNOS) protein level. Exercise increased vessel density in Wistar rats due to higher VEGFR-2 (+17%) and eNOS (+31%) protein level. Captopril and perindopril attenuated exercise-induced angiogenesis in Wistar rats, but the attenuation was small in the perindopril group, and this response was mediated by higher eNOS levels in the Per group compared to the Cap group. Exercise increased myocardial CD in Wistar rats in all groups and treatment did not attenuate it. Both exercise and pharmacological treatment reduced BP of SHR similarly. Rarefaction was found in TA of SHR compared to Wistar, due to lower levels of VEGF (−26%) and eNOS (−27%) and treatment did not avoid this response. Exercise prevented these reductions in control SHR. While rats treated with perindopril showed angiogenesis in the TA muscle after training, those rats treated with captopril showed attenuated angiogenesis (−18%). This response was also mediated by lower eNOS levels in Cap group compared with Per and control group. Myocardial CD was reduced in all sedentary hypertensive compared with Wistar and training restored the number of vessels compared with sedentary SHR. In conclusion, taken into account only the aspect of vessel growth, since both pharmacological treatments reduced BP in SHR, the result of the present study suggests that perindopril could be a drug of choice over captopril for hypertensive practitioners of aerobic physical exercises, especially considering that it does not attenuate angiogenesis induced by aerobic physical training in skeletal and cardiac muscles.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Department of Physical Education School of Sciences São Paulo State UniversityJoint Graduate Program in Physiological Sciences (PIPGCF) Federal University of São Carlos and São Paulo State UniversityDepartment of Biological Sciences Bauru School of Dentistry University of São Paulo (USP)Department of Physical Education School of Sciences São Paulo State UniversityJoint Graduate Program in Physiological Sciences (PIPGCF) Federal University of São Carlos and São Paulo State UniversityCNPq: 142237/2014 311071/2020-1FAPESP: 2019/25603-6 2014/23229-6CAPES: 88882.426901/2019-01 001 88887.634301/2021-00Universidade Estadual Paulista (UNESP)Universidade de São Paulo (USP)Macedo, Anderson G. [UNESP]Miotto, Danyelle S. [UNESP]Tardelli, Lidieli P. [UNESP]Santos, Carlos F.Amaral, Sandra L. [UNESP]2023-07-29T14:02:27Z2023-07-29T14:02:27Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.3389/fphys.2023.1147525Frontiers in Physiology, v. 14.1664-042Xhttp://hdl.handle.net/11449/24910110.3389/fphys.2023.11475252-s2.0-85161051075Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengFrontiers in Physiologyinfo:eu-repo/semantics/openAccess2024-04-23T15:23:28Zoai:repositorio.unesp.br:11449/249101Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T17:51:55.276443Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
title Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
spellingShingle Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
Macedo, Anderson G. [UNESP]
ACE inhibitors
aerobic training
eNOS
tibialis anterior
VEGF
vessel growth
title_short Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
title_full Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
title_fullStr Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
title_full_unstemmed Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
title_sort Exercise-induced angiogenesis is attenuated by captopril but maintained under perindopril treatment in hypertensive rats
author Macedo, Anderson G. [UNESP]
author_facet Macedo, Anderson G. [UNESP]
Miotto, Danyelle S. [UNESP]
Tardelli, Lidieli P. [UNESP]
Santos, Carlos F.
Amaral, Sandra L. [UNESP]
author_role author
author2 Miotto, Danyelle S. [UNESP]
Tardelli, Lidieli P. [UNESP]
Santos, Carlos F.
Amaral, Sandra L. [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Macedo, Anderson G. [UNESP]
Miotto, Danyelle S. [UNESP]
Tardelli, Lidieli P. [UNESP]
Santos, Carlos F.
Amaral, Sandra L. [UNESP]
dc.subject.por.fl_str_mv ACE inhibitors
aerobic training
eNOS
tibialis anterior
VEGF
vessel growth
topic ACE inhibitors
aerobic training
eNOS
tibialis anterior
VEGF
vessel growth
description Angiogenesis is an important exercise-induced response to improve blood flow and decrease vascular resistance in spontaneously hypertensive rats (SHR), but some antihypertensive drugs attenuate this effect. This study compared the effects of captopril and perindopril on exercise-induced cardiac and skeletal muscle angiogenesis. Forty-eight Wistar rats and 48 SHR underwent 60 days of aerobic training or were kept sedentary. During the last 45 days, rats were treated with captopril, perindopril or water (Control). Blood pressure (BP) measurements were taken and histological samples from the tibialis anterior (TA) and left ventricle (LV) muscles were analyzed for capillary density (CD) and vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2) and endothelial nitric oxide synthase (eNOS) protein level. Exercise increased vessel density in Wistar rats due to higher VEGFR-2 (+17%) and eNOS (+31%) protein level. Captopril and perindopril attenuated exercise-induced angiogenesis in Wistar rats, but the attenuation was small in the perindopril group, and this response was mediated by higher eNOS levels in the Per group compared to the Cap group. Exercise increased myocardial CD in Wistar rats in all groups and treatment did not attenuate it. Both exercise and pharmacological treatment reduced BP of SHR similarly. Rarefaction was found in TA of SHR compared to Wistar, due to lower levels of VEGF (−26%) and eNOS (−27%) and treatment did not avoid this response. Exercise prevented these reductions in control SHR. While rats treated with perindopril showed angiogenesis in the TA muscle after training, those rats treated with captopril showed attenuated angiogenesis (−18%). This response was also mediated by lower eNOS levels in Cap group compared with Per and control group. Myocardial CD was reduced in all sedentary hypertensive compared with Wistar and training restored the number of vessels compared with sedentary SHR. In conclusion, taken into account only the aspect of vessel growth, since both pharmacological treatments reduced BP in SHR, the result of the present study suggests that perindopril could be a drug of choice over captopril for hypertensive practitioners of aerobic physical exercises, especially considering that it does not attenuate angiogenesis induced by aerobic physical training in skeletal and cardiac muscles.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-29T14:02:27Z
2023-07-29T14:02:27Z
2023-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3389/fphys.2023.1147525
Frontiers in Physiology, v. 14.
1664-042X
http://hdl.handle.net/11449/249101
10.3389/fphys.2023.1147525
2-s2.0-85161051075
url http://dx.doi.org/10.3389/fphys.2023.1147525
http://hdl.handle.net/11449/249101
identifier_str_mv Frontiers in Physiology, v. 14.
1664-042X
10.3389/fphys.2023.1147525
2-s2.0-85161051075
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers in Physiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128868419108864